INFI Annual Total Long Term Liabilities
$47.57 M
-$2.34 M-4.69%
31 December 2022
Summary:
As of January 21, 2025, INFI annual total long term liabilities is $47.57 million, with the most recent change of -$2.34 million (-4.69%) on December 31, 2022. During the last 3 years, it has risen by +$15.98 million (+50.60%).INFI Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Quarterly Long Term Liabilities
$46.57 M
-$410.00 K-0.87%
30 June 2023
Summary:
As of January 21, 2025, INFI quarterly total long term liabilities is $46.57 million, with the most recent change of -$410.00 thousand (-0.87%) on June 30, 2023. Over the past year, it has dropped by -$2.05 million (-4.22%).INFI Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.7% | -4.2% |
| 3 y3 years | +50.6% | -9.0% |
| 5 y5 years | +10000.0% | +10000.0% |
INFI Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -60.4% | -62.8% |
Infinity Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $46.57 M(-0.9%) |
| Mar 2023 | - | $46.98 M(-1.2%) |
| Dec 2022 | $47.57 M(-4.7%) | $47.57 M(-1.4%) |
| Sept 2022 | - | $48.27 M(-0.7%) |
| June 2022 | - | $48.63 M(-1.2%) |
| Mar 2022 | - | $49.20 M(-1.4%) |
| Dec 2021 | $49.91 M(-2.6%) | $49.91 M(-0.4%) |
| Sept 2021 | - | $50.12 M(-0.8%) |
| June 2021 | - | $50.50 M(-0.8%) |
| Mar 2021 | - | $50.89 M(-0.7%) |
| Dec 2020 | $51.26 M(+62.3%) | $51.26 M(+0.0%) |
| Sept 2020 | - | $51.26 M(+0.2%) |
| June 2020 | - | $51.16 M(+0.6%) |
| Mar 2020 | - | $50.88 M(+61.1%) |
| Dec 2019 | $31.59 M(>+9900.0%) | $31.59 M(-0.5%) |
| Sept 2019 | - | $31.74 M(+3.5%) |
| June 2019 | - | $30.68 M(+10.0%) |
| Mar 2019 | - | $27.88 M(>+9900.0%) |
| Dec 2018 | $38.00 K(+35.7%) | $38.00 K(+5.6%) |
| Sept 2018 | - | $36.00 K(+16.1%) |
| June 2018 | - | $31.00 K(+14.8%) |
| Mar 2018 | - | $27.00 K(-3.6%) |
| Dec 2017 | $28.00 K(-99.9%) | $28.00 K(+7.7%) |
| Sept 2017 | - | $26.00 K(-99.9%) |
| June 2017 | - | $21.01 M(+9.2%) |
| Mar 2017 | - | $19.24 M(-0.5%) |
| Dec 2016 | $19.34 M(-83.9%) | $19.34 M(-19.0%) |
| Sept 2016 | - | $23.88 M(-1.3%) |
| June 2016 | - | $24.19 M(-78.4%) |
| Mar 2016 | - | $112.08 M(-6.8%) |
| Dec 2015 | $120.21 M(+14.7%) | $120.21 M(-4.1%) |
| Sept 2015 | - | $125.30 M(+31.4%) |
| June 2015 | - | $95.39 M(-6.7%) |
| Mar 2015 | - | $102.24 M(-2.4%) |
| Dec 2014 | $104.80 M(+1349.6%) | $104.80 M(+12.8%) |
| Sept 2014 | - | $92.90 M(>+9900.0%) |
| June 2014 | - | $594.00 K(-1.8%) |
| Mar 2014 | - | $605.00 K(-91.6%) |
| Dec 2013 | $7.23 M(+6.4%) | $7.23 M(+3.0%) |
| Sept 2013 | - | $7.02 M(+0.6%) |
| June 2013 | - | $6.97 M(+1.9%) |
| Mar 2013 | - | $6.84 M(+0.7%) |
| Dec 2012 | $6.79 M(-91.5%) | $6.79 M(+1020.8%) |
| Sept 2012 | - | $606.00 K(-99.2%) |
| June 2012 | - | $79.35 M(-0.5%) |
| Mar 2012 | - | $79.73 M(-0.4%) |
| Dec 2011 | $80.07 M | $80.07 M(+81.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $44.20 M(-2.4%) |
| June 2011 | - | $45.27 M(-2.7%) |
| Mar 2011 | - | $46.51 M(-1.7%) |
| Dec 2010 | $47.33 M(-10.4%) | $47.33 M(+35.9%) |
| Sept 2010 | - | $34.83 M(-4.3%) |
| June 2010 | - | $36.39 M(-2.2%) |
| Mar 2010 | - | $37.21 M(-29.5%) |
| Dec 2009 | $52.80 M(+117.4%) | $52.80 M(+35.7%) |
| Sept 2009 | - | $38.90 M(-2.1%) |
| June 2009 | - | $39.72 M(-2.0%) |
| Mar 2009 | - | $40.54 M(+66.9%) |
| Dec 2008 | $24.29 M(-54.9%) | $24.29 M(-41.7%) |
| Sept 2008 | - | $41.68 M(-5.8%) |
| June 2008 | - | $44.23 M(-5.5%) |
| Mar 2008 | - | $46.80 M(-13.1%) |
| Dec 2007 | $53.84 M(-20.1%) | $53.84 M(-6.4%) |
| Sept 2007 | - | $57.50 M(-4.4%) |
| June 2007 | - | $60.13 M(-5.5%) |
| Mar 2007 | - | $63.62 M(-5.6%) |
| Dec 2006 | $67.39 M(+2578.1%) | $67.39 M(-16.8%) |
| Sept 2006 | - | $80.97 M(+9270.0%) |
| Mar 2006 | - | $864.10 K(-65.7%) |
| Dec 2005 | $2.52 M(+1521.3%) | $2.52 M(+785.1%) |
| Sept 2005 | - | $284.30 K(-30.8%) |
| June 2005 | - | $410.80 K(+162.5%) |
| Mar 2005 | - | $156.50 K(+0.8%) |
| Dec 2004 | $155.20 K(+58.4%) | $155.20 K(+5.1%) |
| Sept 2004 | - | $147.60 K(+10.1%) |
| June 2004 | - | $134.10 K(+12.4%) |
| Mar 2004 | - | $119.30 K(+21.7%) |
| Dec 2003 | $98.00 K(-76.1%) | $98.00 K(-4.4%) |
| Sept 2003 | - | $102.50 K(-62.6%) |
| June 2003 | - | $274.20 K(-22.1%) |
| Mar 2003 | - | $351.80 K(-14.4%) |
| Dec 2002 | $410.90 K(-65.1%) | $410.90 K(-22.0%) |
| Sept 2002 | - | $526.50 K(-25.4%) |
| June 2002 | - | $705.50 K(-7.7%) |
| Mar 2002 | - | $764.00 K(-35.1%) |
| Dec 2001 | $1.18 M(+15.6%) | $1.18 M(+19.6%) |
| Sept 2001 | - | $984.30 K(+6.2%) |
| June 2001 | - | $927.20 K(+1.6%) |
| Mar 2001 | - | $912.40 K(-10.4%) |
| Dec 2000 | $1.02 M(-48.1%) | $1.02 M(+25.5%) |
| Sept 2000 | - | $811.50 K(-10.4%) |
| June 2000 | - | $905.30 K(-64.6%) |
| Mar 2000 | - | $2.56 M |
| Dec 1999 | $1.96 M | - |
FAQ
- What is Infinity Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Infinity Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Infinity Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of INFI is $47.57 M
What is the all time high annual total long term liabilities for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high annual total long term liabilities is $120.21 M
What is Infinity Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, INFI annual total long term liabilities has changed by -$2.34 M (-4.69%)
What is Infinity Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of INFI is $46.57 M
What is the all time high quarterly long term liabilities for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high quarterly total long term liabilities is $125.30 M
What is Infinity Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, INFI quarterly total long term liabilities has changed by -$2.05 M (-4.22%)